Xtant Medical Holdings (XTNT) Change in Account Payables (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Change in Account Payables came in at -$399000.0 in Q3 2025, down 130.57% year-on-year from $1.3 million in Q3 2024, and down 4090.0% on a QoQ basis from $10000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Change in Account Payables (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Change in Account Payables data on file, last reported at -$399000.0 in Q3 2025.
- On a quarterly basis, Change in Account Payables fell 130.57% year-over-year to -$399000.0 in Q3 2025; TTM through Sep 2025 was -$1.5 million, a 151.68% decrease from a year earlier, with the FY2024 full-year figure at $1.0 million, down 65.34% from the prior year.
- Change in Account Payables for Q3 2025 stood at -$399000.0, down from $10000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for XTNT reached as high as $1.7 million in Q4 2023 and fell as low as -$890000.0 in Q1 2025.
- Historically, Change in Account Payables has averaged $172473.7 across 5 years, with a median of $151000.0 in 2021.
- Across the five-year window, Change in Account Payables surged 813.04% in 2024 and sank 280.89% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $260000.0 in 2021, then slumped by 211.15% to -$289000.0 in 2022, then soared by 682.01% to $1.7 million in 2023, then slumped by 115.28% to -$257000.0 in 2024, then tumbled by 55.25% to -$399000.0 in 2025.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$399000.0 in Q3 2025, $10000.0 in Q2 2025, and -$890000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -399,000.00 |
| Sep 30, 2025 | -399,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | -890,000.00 |
| Mar 31, 2025 | -890,000.00 |
| Dec 31, 2024 | -257,000.00 |
| Dec 31, 2024 | -257,000.00 |
| Sep 30, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | -507,000.00 |
| Jun 30, 2024 | -507,000.00 |
| Mar 31, 2024 | 492,000.00 |
| Mar 31, 2024 | 492,000.00 |
| Dec 31, 2023 | 1.68 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 344,000.00 |
| Sep 30, 2023 | 344,000.00 |
| Jun 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.02 Mn |